Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
Department of Respiratory Medicine, Tropical and Infectious Disease Unit, Intensive Care Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
BMJ Open Respir Res. 2020 Jul;7(1). doi: 10.1136/bmjresp-2020-000639.
The aim of this case series is to describe and evaluate our experience of continuous positive airway pressure (CPAP) to treat type 1 respiratory failure in patients with COVID-19. CPAP was delivered in negative pressure rooms in the newly repurposed infectious disease unit. We report a cohort of 24 patients with type 1 respiratory failure and COVID-19 admitted to the Royal Liverpool Hospital between 1 April and 30 April 2020. Overall, our results were positive; we were able to safely administer CPAP outside the walls of a critical care or high dependency unit environment and over half of patients (58%) avoided mechanical ventilation and a total of 19 out of 24 (79%) have survived and been discharged from our care.
本病例系列旨在描述和评估我们使用持续气道正压通气（CPAP）治疗 COVID-19 患者 1 型呼吸衰竭的经验。CPAP 在新改建的传染病病房中在负压病房中提供。我们报告了 2020 年 4 月 1 日至 4 月 30 日期间在皇家利物浦医院收治的 24 例 1 型呼吸衰竭和 COVID-19 患者的队列。总体而言，我们的结果是积极的；我们能够在重症监护或高依赖病房环境之外安全地使用 CPAP，超过一半的患者（58%）避免了机械通气，共有 24 名患者中的 19 名（79%）存活并从我们的治疗中出院。
